Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Phosphatidylinositol 3-Kinase p85 Adaptor Function in T-cells
CO-STIMULATION AND REGULATION OF CYTOKINE TRANSCRIPTION
INDEPENDENT OF ASSOCIATED p110*
Hyun
Kang§,
Helga
Schneider§¶, and
Christopher E.
Rudd¶**
From the Department of Cancer Immunology and AIDS,
the § Dana-Farber Cancer Institute and Departments of
Medicine and Pathology, Harvard Medical School,
Boston, Massachusetts 02115, and the ¶ Department of Haematology,
Hammersmith Hospital, Imperial College School of Medicine, Du Cane
Road, London, W12 0NN United Kingdom
Phosphatidylinositol 3-kinase (PI3K) is a key
regulator of a variety of cellular functions from cytoskeletal
organization,vesicular trafficking, and cell proliferation to
apoptosis. Theenzyme complex is comprised of an 85-kDa adaptor (p85)
coupledto a 110-kDa catalytic subunit (p110). While the function of
PI3Khas been largely attributed to the generation of D-3 lipids, anunanswered question has been whether p85 with a number of motifs(SH2,
SH3, BcR homology (BH) region) can generate independentintracellular
signals. In this study, we demonstrate that p85lacking p110 (p85)
can activate NFAT transcription in T-cellhybridomas and normal
splenocytes. This up-regulatory effect wasunaffected by inhibition of
PI 3-kinase, and cooperated specificallywith Rac1, but not related
family members. Stimulation correlatedwith Rac1 binding and was lost
with the deletion of the BH domain.Lastly, the CD28-p85 chimera
also cooperated with TcR/CD3 toprovide co-signals that enhanced IL-2
transcription. Our findingsidentify for the first time p85 as
an adaptor that operates independentlyof the classic PI 3-kinase
catalytic pathway and further showsthat this pathway can provide
co-signals in the regulation ofT-cellfunction.
The editors suggest the following Related Resources on Science sites:
VIRTUAL JOURNAL
Ana González-García, Elia Garrido, Carmen Hernández, Beatriz Alvarez, Concepción Jiménez, Doreen A. Cantrell, Nicholas Pullen, and Ana C. Carrera (4 January 2002) J. Biol. Chem.277 (2), 1500.
[DOI: 10.1074/jbc.M103808200] |Abstract »|Full Text »|PDF »
Klaus Okkenhaug and Bart Vanhaesebroeck (16 January 2001) Sci. STKE2001 (65), pe1.
[DOI: 10.1126/scisignal.652001pe1] |Abstract »|Full Text »|PDF »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
The signalling factor PI3K is a specific regulator of the clathrin-independent dynamin-dependent endocytosis of IL-2 receptors.
C. Basquin, V. Malarde, P. Mellor, D. H. Anderson, V. Meas-Yedid, J.-C. Olivo-Marin, A. Dautry-Varsat, and N. Sauvonnet (2013)
J. Cell Sci.
126, 1099-1108
|Abstract »|Full Text »|PDF »
Ether-linked diglycerides inhibit vascular smooth muscle cell growth via decreased MAPK and PI3K/Akt signaling.
K. L. Houck, T. E. Fox, L. Sandirasegarane, and M. Kester (2008)
Am J Physiol Heart Circ Physiol
295, H1657-H1668
|Abstract »|Full Text »|PDF »
Cyclosporin A and FK506 Inhibit IL-12p40 Production through the Calmodulin/Calmodulin-dependent Protein Kinase-activated Phosphoinositide 3-Kinase in Lipopolysaccharide-stimulated Human Monocytic Cells.
W. Ma, S. Mishra, K. Gee, J. P. Mishra, D. Nandan, N. E. Reiner, J. B. Angel, and A. Kumar (2007)
J. Biol. Chem.
282, 13351-13362
|Abstract »|Full Text »|PDF »
The p85{alpha} Regulatory Subunit of Phosphoinositide 3-Kinase Potentiates c-Jun N-Terminal Kinase-Mediated Insulin Resistance.
C. M. Taniguchi, J. O. Aleman, K. Ueki, J. Luo, T. Asano, H. Kaneto, G. Stephanopoulos, L. C. Cantley, and C. R. Kahn (2007)
Mol. Cell. Biol.
27, 2830-2840
|Abstract »|Full Text »|PDF »
T-cell function is partially maintained in the absence of class IA phosphoinositide 3-kinase signaling.
J. A. Deane, M. G. Kharas, J. S. Oak, L. N. Stiles, J. Luo, T. I. Moore, H. Ji, C. Rommel, L. C. Cantley, T. E. Lane, et al. (2007)
Blood
109, 2894-2902
|Abstract »|Full Text »|PDF »
Complement regulatory protein Crry/p65-mediated signaling in T lymphocytes: role of its cytoplasmic domain and partitioning into lipid rafts.
A. Jimenez-Perianez, G. Ojeda, G. Criado, A. Sanchez, E. Pini, J. Madrenas, J. M. Rojo, and P. Portoles (2005)
J. Leukoc. Biol.
78, 1386-1396
|Abstract »|Full Text »|PDF »
Enhanced T Cell Proliferation in Mice Lacking the p85{beta} Subunit of Phosphoinositide 3-Kinase.
J. A. Deane, M. J. Trifilo, C. M. Yballe, S. Choi, T. E. Lane, and D. A. Fruman (2004)
J. Immunol.
172, 6615-6625
|Abstract »|Full Text »|PDF »
Positive and Negative Roles of p85{alpha} and p85{beta} Regulatory Subunits of Phosphoinositide 3-Kinase in Insulin Signaling.
K. Ueki, D. A. Fruman, C. M. Yballe, M. Fasshauer, J. Klein, T. Asano, L. C. Cantley, and C. R. Kahn (2003)
J. Biol. Chem.
278, 48453-48466
|Abstract »|Full Text »|PDF »
Evidence That Phosphatidylinositol 3-Kinase- and Mitogen-activated Protein Kinase Kinase-4/c-Jun NH2-terminal Kinase-dependent Pathways Cooperate to Maintain Lung Cancer Cell Survival.
H.-Y. Lee, H. Srinivas, D. Xia, Y. Lu, R. Superty, R. LaPushin, C. Gomez-Manzano, A. M. Gal, G. L. Walsh, T. Force, et al. (2003)
J. Biol. Chem.
278, 23630-23638
|Abstract »|Full Text »|PDF »
Interaction between von Willebrand factor and glycoprotein Ib activates Src kinase in human platelets: role of phosphoinositide 3-kinase.
Y. Wu, N. Asazuma, K. Satoh, Y. Yatomi, T. Takafuta, M. C. Berndt, and Y. Ozaki (2003)
Blood
101, 3469-3476
|Abstract »|Full Text »|PDF »
Necessity of tyrosine 719 and phosphatidylinositol 3'-kinase-mediated signal pathway in constitutive activation and oncogenic potential of c-kit receptor tyrosine kinase with the Asp814Val mutation.
K. Hashimoto, I. Matsumura, T. Tsujimura, D.-K. Kim, H. Ogihara, H. Ikeda, S. Ueda, M. Mizuki, H. Sugahara, H. Shibayama, et al. (2003)
Blood
101, 1094-1102
|Abstract »|Full Text »|PDF »